Alaska Oncology and Hematology — Anchorage, Alaska

Alaska Oncology and Hematology is a clinical research site located in Anchorage, Alaska, United States 99508.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Alaska Oncology and Hematology has participated in 18 clinical trials with 13 currently active.

Therapeutic areas: Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Follicular Lymphoma, Chronic Myelogenous Leukemia - Chronic Phase.

Sponsors: Bristol-Myers Squibb, Celgene, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alaska Oncology and Hematology?

Alaska Oncology and Hematology has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alaska Oncology and Hematology conducted?

Alaska Oncology and Hematology has 18 clinical trials on record, with 13 currently active. Their work covers Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Follicular Lymphoma, Chronic Myelogenous Leukemia - Chronic Phase.

Is Alaska Oncology and Hematology accredited by Crixeo Health?

Alaska Oncology and Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alaska Oncology and Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.